Wednesday, February 10, 2010, 8:49pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Baxter International Inc. (BAX)

At 5:00AM SGT: 56.38 USD   0.00 (0.00%)  
 MORE ON BAX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 BAXTER INTL INC (NYSE:BAX) Delayed quote dataEdit
Last Trade:56.38 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:56.38
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:65.50
Day's Range:N/A - N/A
52wk Range:45.46 - 61.88
Volume:0
Avg Vol (3m):4,337,730
Market Cap:33.99B
P/E (ttm):15.83
EPS (ttm):3.56
Div & Yield:1.07 (1.90%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add BAX to Portfolio   Download Data

 HEADLINES 
•Becton Recalls Catheters
Zacks.com (Wed 4:49am)
•Germany Cancels Swine Flu Vaccines
at BusinessWeek (Tue 11:52pm)
•Cloning the Activist Masters' Portfolios
at Seeking Alpha (Tue 2:21pm)
•New Device Promises To Make Heart Surgery Easier And Safer
Investor's Business Daily (Sat, Feb 6)
•Baxter lobbying budget tops $1 million for 4Q
AP (Sat, Feb 6)
•Baxter Downgraded
Zacks.com (Fri, Feb 5)
•3 Best Hedge Fund Healthcare Ideas
at Seeking Alpha (Wed, Feb 3)
•Home Health Care And Diagnostics Companies High Target Environment For Acquisitions According To RBC Capital Markets Expert Equity Analyst
Wall Street Transcript (Wed, Feb 3)
•Haemonetics Misses Zacks Estimate
Zacks.com (Wed, Feb 3)
•You Can't Afford This Huge Mistake
at Motley Fool (Tue, Feb 2)
•Becton Stays Neutral
Zacks.com (Tue, Feb 2)
•[$$] A Stock Generalist Gets Specific
at Barrons.com (Tue, Feb 2)
•Baxter, Becton Are Poised to Gain This Year
at TheStreet.com (Tue, Feb 2)
•Your Money with Chuck Jaffe: Dow forecaster puts money into health care, tech
at MarketWatch (Tue, Feb 2)
•New Star Analyst Rankings for BAXTER INTL INC
StarMine (Sat, Jan 30)
•UPDATE - U.S. FDA recalls Baxter hemodialysis system
at Reuters (Sat, Jan 30)
More Headlines for BAX...
 ANALYST 
EPS Est (next year) (Dec-09) :3.80
EPS Est (in 2 years) (Dec-10) :4.29
Avg Rec (current)*:1.8
PEG Ratio:1.39
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices